(Q38081399)

28 August 2017

title

Recent advances using immunomodulators for inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

28 August 2017

main subject

0 references

author

Ole Haagen Nielsen

series ordinal

1

1 reference

28 August 2017

4

Gerhard Rogler

1 reference

28 August 2017

author name string

Jacob Tveiten Bjerrum

series ordinal

2

1 reference

28 August 2017

Hans Herfarth

series ordinal

3

1 reference

28 August 2017

publication date

13 February 2013

1 reference

The Journal of Clinical Pharmacology

28 August 2017

published in

1 reference

28 August 2017

volume

53

1 reference

28 August 2017

issue

6

1 reference

28 August 2017

page(s)

575-588

1 reference

The chemistry and biochemistry of purine analogs

28 August 2017

cites work

1 reference

Old and new drugs used in rheumatoid arthritis: a historical perspective. Part 1: the older drugs

21 January 2018

1 reference

Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease

21 January 2018

1 reference

Refractory IBD: medical management

21 January 2018

1 reference

Azathioprine suppresses ezrin-radixin-moesin-dependent T cell-APC conjugation through inhibition of Vav guanosine exchange activity on Rac proteins

21 January 2018

1 reference

CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes

21 January 2018

1 reference

Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine

21 January 2018

1 reference

The clinical pharmacology of 6-mercaptopurine

21 January 2018

1 reference

Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity

21 January 2018

1 reference

Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase

21 January 2018

1 reference

Prospective study of the effects of concomitant medications on thiopurine metabolism in inflammatory bowel disease.

21 January 2018

1 reference

6-Thioguanine therapy in Crohn's disease--observational data in Swedish patients.

21 January 2018

1 reference

A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with inflammatory bowel disease

21 January 2018

1 reference

6-Thioguanine-related hepatotoxicity in patients with inflammatory bowel disease: dose or level dependent?

21 January 2018

1 reference

Gastrointestinal and liver adverse effects of drugs used for treating IBD.

21 January 2018

1 reference

Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients.

21 January 2018

1 reference

American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease

21 January 2018

1 reference

Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine

21 January 2018

1 reference

The pharmacogenetics of methotrexate in inflammatory bowel disease

21 January 2018

1 reference

Advances in individual prediction of methotrexate toxicity: a review

21 January 2018

1 reference

Pharmacokinetics and pharmacodynamics of methotrexate in non-neoplastic diseases

21 January 2018

1 reference

Methotrexate in rheumatoid arthritis. An update

21 January 2018

1 reference

Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease

21 January 2018

1 reference

Assessment of thiopurine S-methyltransferase activity in patients prescribed thiopurines: a systematic review

21 January 2018

1 reference

Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy

21 January 2018

1 reference

Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy

21 January 2018

1 reference

Novel strategies in the thiopurine treatment of inflammatory bowel disease.

21 January 2018

1 reference

6-mercaptopurine in patients with inflammatory bowel disease and previous digestive intolerance of azathioprine

21 January 2018

1 reference

Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery

21 January 2018

1 reference

Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease.

21 January 2018

1 reference

Effect of early immunomodulator use in moderate to severe pediatric Crohn disease

21 January 2018

1 reference

Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis

21 January 2018

1 reference

Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial

21 January 2018

1 reference

Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research

21 January 2018

1 reference

Preparing the Patient for Immunosuppressive Therapy

21 January 2018

1 reference

Switching metabolism—can two drugs be better than one?

21 January 2018

1 reference

Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease

21 January 2018

1 reference

Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease

21 January 2018

1 reference

Combination of thiopurines and allopurinol: adverse events and clinical benefit in IBD

21 January 2018

1 reference

Cumulative experience with short- and long-term toxicity to 6-mercaptopurine in the treatment of Crohn's disease and ulcerative colitis

21 January 2018

1 reference

Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD

21 January 2018

1 reference

Drug-induced hepatotoxicity.

21 January 2018

1 reference

Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine

21 January 2018

1 reference

Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine

21 January 2018

1 reference

Incidence of liver toxicity in inflammatory bowel disease patients treated with methotrexate: a meta-analysis of clinical trials

21 January 2018

1 reference

Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease.

21 January 2018

1 reference

Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease

21 January 2018

1 reference

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

21 January 2018

1 reference

A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease

21 January 2018

1 reference

The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: results from a population-based cohort in Eastern Europe

21 January 2018

1 reference

Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease

21 January 2018

1 reference

Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population-based case-control study

21 January 2018

1 reference

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

21 January 2018

1 reference

Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis

21 January 2018

1 reference

Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle.

21 January 2018

1 reference

Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease

21 January 2018

1 reference

Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease

21 January 2018

1 reference

Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease

21 January 2018

1 reference

EBV-associated diffuse large B-cell lymphoma in a psoriatic treated with methotrexate

21 January 2018

1 reference

Randomised controlled trial of azathioprine withdrawal in ulcerative colitis

21 January 2018

1 reference

The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review

21 January 2018

1 reference

A search for the optimal duration of treatment with 6-mercaptopurine for ulcerative colitis

21 January 2018

1 reference

Relapse rate following azathioprine withdrawal in maintaining remission for Crohn's disease: a meta-analysis

21 January 2018

1 reference

Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission

21 January 2018

1 reference

Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease

21 January 2018

1 reference

Immunomodulators for all patients with inflammatory bowel disease?

21 January 2018

1 reference

Changes in liver biochemistry during methotrexate use for inflammatory bowel disease

21 January 2018

1 reference

Methotrexate: a useful alternative in Crohn's disease?

21 January 2018

1 reference

European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

21 January 2018

1 reference

Risks and benefits of combining immunosuppressives and biological agents in inflammatory bowel disease: is the synergy worth the risk?

21 January 2018

1 reference

Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease

21 January 2018

1 reference

Management of Crohn's disease in adults.

21 January 2018

1 reference

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

21 January 2018

1 reference

Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy

21 January 2018

1 reference

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

21 January 2018

1 reference

Therapy of Metronidazole With Azathioprine to Prevent Postoperative Recurrence of Crohn's Disease: A Controlled Randomized Trial

21 January 2018

1 reference

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

21 January 2018

1 reference

Infliximab, azathioprine, or combination therapy for Crohn's disease

21 January 2018

1 reference

Methotrexate for the Treatment of Crohn's Disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCPH.2

1 reference

28 August 2017

1 reference